SMS supporting treatment for people with type 2 diabetes

Not Applicable

Completed

• Conditions: Type 2 diabetes; Nutritional, Metabolic, Endocrine; Non-insulin-dependent diabetes mellitus

• Registration Number: ISRCTN70768808
• Lead Sponsor: niversity of Oxford

Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31199346 results (added 17/06/2019) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33451308/ intervention development (added 18/01/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34418987/ Process evaluation (added 23/08/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34674688/ (added 26/10/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-08-03
• Study Completion: 2019-04-01
• Last Update Posted: 26 September 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1066

Inclusion Criteria

1. Participant is willing and able to give informed consent for participation in the study
2. Able to communicate in one of the predominant official languages spoken in the Western Cape (Cape Town) and Gauteng (Johannesburg) provinces (e.g. English, Afrikaans, isiXhosa, isiZulu and Sesotho), in South Africa and in Malawi, English or the Chichewa language
3. Male or female, aged 18 years of above
4. A diagnosis of type 2 diabetes
5. Taking oral glucose lowering treatment
6. Has access to a mobile-phone (shared access is allowed with permission of phone owner)
7. Knows how to use SMS (it is okay if participant needs help to send or retrieve SMS)
8. Currently lives in the community served by the clinic and plans to live there for the next 18 months

Exclusion Criteria

1. Within three months of a hospital admission for hyperglycaemia or hypoglycaemia
2. Pregnant or within three months post-partum by self-report or with plans to become pregnant in the next 12 months
3. A terminal medical condition
4. Another member of the household already recruited to the trial
5. Participation in the formative work for the intervention

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 11/10/2016 (methods and timepoints of measurement added 26/10/2017):Change in HbA1c, measured with International Federation of Clinical Chemistry calibrated analyzers linked to a quality assurance scheme from baseline to one year Previous primary outcome measure (methods and timepoints of measurement added 26/10/2017):Change in HbA1c and the proportion of patients collecting 80% or greater of their agreed diabetes related medication derived from routine clinic data